Remission, Low Disease Activity and Improvement of Pain and Function in Psoriatic Arthritis Patients Treated With IL-12 23 and IL-17 Inhibitors. A Multicenter Prospective Study. Reumatismo 2020, 72 (1), 52-59. https://doi.org/10.4081/reumatismo.2020.1266.